Introduction
Screening for fetal aneuploidy is routinely offered to pregnant women and nuchal translucency (NT) thickness measurement is widely used as part of this screening. Although the risk of aneuploidy increases with NT thickness and no biometric cut-off is advisable (1), increased NT above the 95 th centile irrespective of fetal karyotype has been associated with adverse outcome including mainly cardiac defects and genetic syndromes (2) (3) (4) (5) (6) . Around 1% of all fetuses should show increased nuchal translucency above the 99 th centile for gestational age in an unselected population. Eight studies have addressed the issue of pediatric long-term follow up of chromosomally and anatomically normal fetuses with increased nuchal translucency (7) (8) (9) (10) (11) (12) (13) (14) . Up to 9% of them had developmental delay in early childhood (Table 1 ).
However these figures should be considered with caution owing to the limited number of children studied from heterogeneous populations and using different cut-off values for NT.
Follow-up was incomplete in up to 32% of the cases in some studies and post-natal assessment was often conducted retrospectively and only based on questionnaires to the parents.
The relationship between isolated increased nuchal translucency thickness with normal karyotype in the first trimester and developmental delay in early childhood therefore remains questionable. Data on prospective follow-up assessment are needed to counsel couples following prenatal diagnosis. The objectives of this study were to describe the prevalence of developmental abnormalities as well as the relationship between nuchal translucency thickness and neonatal and pediatric outcome following first trimester measurement of NT ≥99 th centile with normal karyotype .
Population and Methods
We conducted a cohort study in a large unselected pregnant population undergoing first trimester ultrasound screening for fetal aneuploidy in a single health authority. All patients gave oral consent to undergo follow-up and the study was approved by the local ethics committee. Results on the performance of combined first trimester screening using maternal age, NT thickness and maternal serum markers over 2 years in the first 14,934 cases have been reported elsewhere (15) . NT was measured when the crown rump length (CRL) was between 45 and 84 mm. Fetuses with NT measurement ≥ 99 th centile adjusted for gestational age were included in this long-term follow-up study. Cystic hygroma as defined by the presence of two paracervical cystic cavities whether associated with hydrops or not were excluded from the study (16). Patients were counselled regarding the risk of chromosomal abnormality and offered fetal karyotyping whenever appropriate. A detailed ultrasound examination was performed in all chromosomally normal fetuses at between 16 and 18 weeks of gestation to follow-up changes in nuchal translucency thickness and to rule out major fetal anatomical defects including fetal echocardiography. This was repeated at between 22 and 24 weeks of gestation. In cases with persistent increased nuchal fold, parents were counselled that the risk of worsening in utero or delivering a baby with a severe abnormality was higher than in the general population (14) . In addition all cases were offered genetic counselling accounting for family history of malformation, developmental delay or consanguinity.
Follow-up scans were performed monthly up until delivery. Nuchal translucency measurements, fetal karyotype, ultrasound findings and pregnancy outcome were recorded prospectively on a computer database. Post-mortem examination was systematically carried out in cases with intra-uterine death or termination of pregnancy. Adverse prenatal outcome was defined as a composite outcome including termination of pregnancy for fetal malformation, intrauterine death and miscarriage. cut-off for each domain was 2 standard deviations (SD) below the mean score. If the child's score was below 2 SD in one or more domains, further assessment of the child's performance was recommended. Children with a NT measurement < 99 th centile were not followed-up. We anticipated a high loss-for-follow-up rate in a population with no incentive for clinical and developmental follow-up after birth following an uneventful pregnancy. Our study population was therefore compared to an external control group. This control group was made of the 370 full-term control children from a French national population-based cohort study designed in group resulted from random recruitment in all maternity wards from nine French regions covering about one-third of all births in France. Infants were followed from birth up until the age of 5. They were assessed using the same 14 items used in our study to evaluate growth and development at 2 years of age.
Statistical analysis
The analysis focused on fetal and pediatric follow-up and outcome including adverse prenatal outcome, postnatal diagnosis of malformations, as well as development at 2 years of age. The relationship between nuchal translucency and each of these characteristics was analysed by logistic regression with adjustment for both gestational age and maternal age. The shape of the relationship was established using fractional polynomials (20) . Whenever the relationship was not significantly different from linearity, it was summarized by an odds ratio (OR) corresponding to the risk variation for each 1 mm of NT. The developmental characteristics were also compared to those of the external control group by using a chi-squared test. Table 2) . Furthermore development at the age of 2 was similar to that of the controls (Table 3) .
Results

Routine
Discussion
In children born after a prenatal diagnosis of an apparently isolated increased NT with normal karyotype, there was a wide spectrum of abnormalities diagnosed postnatally in 11.1% (18/162) of the cases. Cardiac malformations accounted for about half of all these abnormalities in our population as reported in the literature (6). Our study confirms that fetuses with NT thickness above the 99 th centile and normal karyotype have a high risk of adverse perinatal outcome. However among children born alive, there was no significant association between unexplained increase in first trimester NT thickness and development at 2 years as assessed by clinical examination and ASQ scores, when with a control population.
These results are at odds with previous reports on the risk of developmental delay in these children. This may be partly explained by differences in study-designs. Some studies were conducted in highly biased referral populations (9, 10, 12, 14) , while others were based on unselected populations (8, 11, 13) . We used a cut-off value of 99 th centile for NT since it was reported that a cut-off value of 3.5mm was at or above the 99 th centile for NT thickness throughout the first trimester of pregnancy (21) . However, other studies used variable threshold definitions of abnormal NT thickness that contributed to the variability in their results. Lower cut-off led to lower risk of adverse pregnancy outcome and developmental delay (2.0% to 7.1%) (7,11,13) while higher ones reported higher risks (5.6% to 8.7%) (8, 12) (Table 2 ). Most series included less than 40 children (8,9,13) with loss-for-follow-up rates of up to 15-32% (7, 8, 11) . Our study is unlikely to present a selection bias and pediatric follow-up at the age of 2 was available for all children but 2. Developmental assessment was often conducted without clinical examination (7-9,13) and without comparison with a control group (7) (8) (9) (11) (12) (13) (14) . The only study with few cases lost for follow-up and a control group included 89 children with NT thickness ≥ 3.5mm at 11-14 weeks and reported a prevalence of developmental delay of 1.12%. This was similar to their control group and to the rate reported in our study (10) . Outcome was also poorer in series including cystic hygroma cases (22, 23) , a distinct condition clearly associated with a poor prognosis (24).
Souka et al (6, 14) reported higher risk of adverse outcome with persistent second trimester fetal nuchal fold, including associations with cardiac defects, hydrops, intrauterine death or genetic syndrome. This is concordant with our study where increased NT evolved into nuchal edema or hydrops in the 2 nd trimester of gestation in 6 of 162 fetuses (3.7%). Five of these cases underwent termination of pregnancy and one infant was diagnosed with an unrecognizable syndrome associated with developmental delay at the age of 2.
Development was assessed by pediatric clinical examination as well as by questionnaires answered by the parents at 24 months of age. The psychometric properties of ASQ including validity, inter and intra variability have been ascertained (25) . Sensitivity and specificity to detect developmental delay are about 75% and 86% respectively (25) . The proportion of children with ASQ < 2DS in our study was similar to that reported in normative studies (18%) (25) or in screening programs (16%) (26) . ASQ results obtained in a Norwegian population were similar to American normative data suggesting few ethnic and cultural variations (27).
Counselling should emphasize that when the karyotype is normal and no fetal structural malformation was missed prenatally following resolution of nuchal thickening, the prognosis is not impaired at the age of 2. 
